Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination with Immune Therapies in Subjects with Advanced or Metastatic Malignancies
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.